Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Erik A. M. Beckers"'
Autor:
Ilja Oomen, Marieke Verhagen, Mariarosaria Miranda, Peter Allacher, Erik A. M. Beckers, Nicole M. A. Blijlevens, Johanna G. van der Bom, Michiel Coppens, Mariëtte Driessens, Jeroen C. J. Eikenboom, Karin Fijnvandraat, Shermarke Hassan, Waander L. van Heerde, H. Louise Hooimeijer, Joop H. Jansen, Paul Kaijen, Frank W. G. Leebeek, Daniëlle Meijer, Helmut Paul, Sanna R. Rijpma, Frits R. Rosendaal, Cees Smit, Lize F. D. van Vulpen, Jan Voorberg, Saskia E. M. Schols, Samantha C. Gouw
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesAnti-factor VIII (FVIII) antibodies have been reported to exhibit both neutralizing and non-neutralizing characteristics. This is the first study investigating the full spectrum of FVIII-specific antibodies, including non-neutralizing antib
Externí odkaz:
https://doaj.org/article/597ab8aa3a9e45e5a577ea5c89256fc0
Autor:
Tom W. van de Berg, Mark M. G. Mulder, Teba Alnima, Magdolna Nagy, Rene van Oerle, Erik A. M. Beckers, Tilman M. Hackeng, Anne-Marije Hulshof, Jan-Willem E. M. Sels, Yvonne M. C. Henskens, Iwan C. C. van der Horst, Hugo ten Cate, Henri M. H. Spronk, Bas C. T. van Bussel, MaastrICCht Collaborators
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundCOVID-19 associated coagulopathy (CAC) is associated with an increase in thromboembolic events. Current guidelines recommend prophylactic heparins in the management of CAC. However, the efficacy of this strategy in the intensive care popula
Externí odkaz:
https://doaj.org/article/d4e063b4fb314f20b6c286e5c55e882c
Autor:
Anne‐Fleur Zwagemaker, Fabienne R. Kloosterman, Michiel Coppens, Samantha C. Gouw, Sara Boyce, Catherine N. Bagot, Erik A. M. Beckers, Paul Brons, Giancarlo Castaman, Jeroen Eikenboom, Shannon Jackson, Marieke J. H. A. Kruip, Frank W. G. Leebeek, Karina Meijer, Laurens Nieuwenhuizen, Ingrid Pabinger, Karin Fijnvandraat, the DYNAMO Study Group
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Desmopressin is an important treatment option in nonsevere hemophilia A because it has several benefits compared with factor (F) concentrates, including no inhibitor risk and much lower costs. Despite these advantages, data are li
Externí odkaz:
https://doaj.org/article/a16e8de542a44393ab495934c494f90e
Autor:
Erna C. van Balen, Shermarke Hassan, Cees Smit, Mariette H. E. Driessens, Erik A. M. Beckers, Michiel Coppens, Jeroen C. Eikenboom, Hélène L. Hooimeijer, Frank W. G. Leebeek, Evelien P. Mauser‐Bunschoten, Lize F. D. van Vulpen, Saskia E. M. Schols, Frits R. Rosendaal, Johanna G. van der Bom, Samantha C. Gouw
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background and objectives Treatment availability and comprehensive care have resulted in improved clinical outcomes for persons with hemophilia. Recent data on socioeconomic participation in the Netherlands are lacking. This study assessed p
Externí odkaz:
https://doaj.org/article/db7a7b935ef64b20bf53ebae4067d4c0
Autor:
Maaike W. Blaauwgeers, Marieke J. H. A. Kruip, Erik A. M. Beckers, Michiel Coppens, Jeroen Eikenboom, Karin P. M. vanGalen, Rienk Y. J. Tamminga, Rolf T. Urbanus, Roger E. G. Schutgens, the TiN study group
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 1, Pp 100-105 (2020)
Abstract Background Patients with congenital blood platelet disorders (CPDs) demonstrate a predominantly mucocutaneous bleeding tendency. Repeated bleeds throughout life can have a significant impact on health status–related quality of life (HR‐Q
Externí odkaz:
https://doaj.org/article/0c9d076f8a854bd88108a3b21255e944
Autor:
Cas J. Isfordink, Samantha C. Gouw, Erna C. vanBalen, Shermarke Hassan, Erik A. M. Beckers, Johanna G. van derBom, Michiel Coppens, Jeroen Eikenboom, Kathelijn Fischer, Louise Hooimeijer, Frank W. G. Leebeek, Frits R. Rosendaal, Saskia E. M. Schols, Cees Smit, Lize F. D. vanVulpen, Eveline P. Mauser‐Bunschoten
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 8, Pp n/a-n/a (2021)
Abstract Introduction Persons with hemophilia and hepatitis C virus (HCV) infection have a lower health‐related quality of life (HRQoL) than those never HCV infected. However, it is unknown whether HRQoL after HCV eradication is comparable to indiv
Externí odkaz:
https://doaj.org/article/ab0b8a7c6e744fb3b209acf2c9b4bb45
Autor:
Floor C. J. I. Moenen, Minka J. A. Vries, Patricia J. Nelemans, Katrien J. M. van Rooy, Jeannique R. R. A. Vranken, Paul W. M. Verhezen, Rick J. H. Wetzels, Hugo ten Cate, Harry C. Schouten, Erik A. M. Beckers, Yvonne M. C. Henskens
Publikováno v:
Platelets, Vol 30, Iss 1, Pp 81-87 (2019)
Light transmission aggregation (LTA) is the gold standard for the diagnosis of platelet function disorders (PFDs), but it is time-consuming and limited to specialized laboratories. Whole-blood impedance aggregometry (Multiplate) and platelet function
Externí odkaz:
https://doaj.org/article/821cf6888da845dc965608ac3a7db84b
Autor:
Constance C. F. M. J. Baaten, Floor C. J. I. Moenen, Yvonne M. C. Henskens, Frauke Swieringa, Rick J. H. Wetzels, René van Oerle, Harry F. G. Heijnen, Hugo ten Cate, Graham P. Holloway, Erik A. M. Beckers, Johan W. M. Heemskerk, Paola E. J. van der Meijden
Publikováno v:
Haematologica, Vol 103, Iss 9 (2018)
Severe thrombocytopenia (≤50×109 platelets/L) due to hematological malignancy and intensive chemotherapy is associated with an increased risk of clinically significant bleeding. Since the bleeding risk is not linked to the platelet count only, oth
Externí odkaz:
https://doaj.org/article/24ff6cee022e4bc7a84f0d6f522e5612
Autor:
Floor C. J. I. Heubel‐Moenen, Sanne L. N. Brouns, Linda Herfs, Lara S. Boerenkamp, Natalie J. Jooss, Rick J. H. Wetzels, Paul W. M. Verhezen, Patric Machiels, Karyn Megy, Kate Downes, Johan W. M. Heemskerk, Erik A. M. Beckers, Yvonne M. C. Henskens
Publikováno v:
British Journal of Haematology, 196(6), 1388-1400. Wiley
Patients referred for evaluation of bleeding symptoms occasionally have a prolonged platelet function analyser (PFA) closure time, without evidence for von Willebrand disease or impaired platelet aggregation. The aim of this study was to establish a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab9a4cf720c4c2ee76e7d16f10816adf
https://doi.org/10.1111/bjh.18003
https://doi.org/10.1111/bjh.18003
Autor:
Aukje L Kreuger, Rutger A Middelburg, Erik A M Beckers, Karen M K de Vooght, Jaap Jan Zwaginga, Jean-Louis H Kerkhoffs, Johanna G van der Bom
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0200655 (2018)
INTRODUCTION:Electronic health care data offers the opportunity to study rare events, although detecting these events in large datasets remains difficult. We aimed to develop a model to identify leukemia patients with major hemorrhages within routine
Externí odkaz:
https://doaj.org/article/fedb9b6ce041461fa16c7072c718979e